Exact Mass: 505.2788

Exact Mass Matches: 505.2788

Found 54 metabolites which its exact mass value is equals to given mass value 505.2788, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Capromorelin

N-(1-{3a-benzyl-2-methyl-3-oxo-2H,3H,3aH,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl}-3-(benzyloxy)-1-oxopropan-2-yl)-2-amino-2-methylpropanamide

C28H35N5O4 (505.2689)


   

6-(4-(2,2-Di(4-Fluorophenyl)ethylamino)-1-piperidinyl)-N,N'-di-2-propenyl-1,3,5-triazine-2,4-diamine

6-(4-{[2,2-bis(4-fluorophenyl)ethyl]amino}piperidin-1-yl)-N2,N4-bis(prop-2-en-1-yl)-1,3,5-triazine-2,4-diamine

C28H33F2N7 (505.2765)


   

Stachybotrin C

Stachybotrin C

C31H39NO5 (505.2828)


   

pyrrospirone B

pyrrospirone B

C31H39NO5 (505.2828)


   
   
   

HMB-Val-Ser-Leu-VE

N-(3-hydroxy-2-methylbenzoyl)-L-valyl-N-[(1S,2E)-4-ethoxy-1-(2-methylpropyl)-4-oxo-2-butenyl]-L-serinamide

C26H39N3O7 (505.2788)


   

Val Ser Ser Ser Leu

Val Ser Ser Ser Leu

C21H39N5O9 (505.2748)


   

His Pro Pro Arg

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C22H35N9O5 (505.2761)


   

His Pro Arg Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C22H35N9O5 (505.2761)


   

His Arg Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C22H35N9O5 (505.2761)


   

Pro His Pro Arg

(2S)-5-carbamimidamido-2-{[(2S)-1-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}pentanoic acid

C22H35N9O5 (505.2761)


   

Pro His Arg Pro

(2S)-1-[(2S)-5-carbamimidamido-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanoyl]pyrrolidine-2-carboxylic acid

C22H35N9O5 (505.2761)


   

Pro Pro His Arg

(2S)-5-carbamimidamido-2-[(2S)-3-(1H-imidazol-4-yl)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]pentanoic acid

C22H35N9O5 (505.2761)


   

Pro Pro Arg His

(2S)-2-[(2S)-5-carbamimidamido-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C22H35N9O5 (505.2761)


   

Pro Arg His Pro

(2S)-1-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C22H35N9O5 (505.2761)


   

Pro Arg Pro His

(2S)-2-{[(2S)-1-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C22H35N9O5 (505.2761)


   

Arg His Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C22H35N9O5 (505.2761)


   

Arg Pro His Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C22H35N9O5 (505.2761)


   

Arg Pro Pro His

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C22H35N9O5 (505.2761)


   

(9-Butyl-9-fluorenyl)dicyclohexylphosphine tetrafluoroborate,cataCXium(R) FBu

(9-Butyl-9-fluorenyl)dicyclohexylphosphine tetrafluoroborate,cataCXium(R) FBu

C29H39BF4P (505.2818)


   

1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-ium-1-yl]butan-1-one,chloride

1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-ium-1-yl]butan-1-one,chloride

C32H40ClNO2 (505.2747)


   

Capromorelin

Capromorelin

C28H35N5O4 (505.2689)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76358 - Growth Hormone-Releasing Hormone Analogue

   

4-[6-[(8-Cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester

4-[6-[(8-Cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester

C27H35N7O3 (505.2801)


   

TAUROLITHOCHOLIC ACID SODIUM SALT

TAUROLITHOCHOLIC ACID SODIUM SALT

C26H44NNaO5S (505.2838)


Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist[1].

   

Telapristone acetate

Telapristone acetate

C31H39NO5 (505.2828)


C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist

   

6-(4-(2,2-Di(4-Fluorophenyl)ethylamino)-1-piperidinyl)-N,N-di-2-propenyl-1,3,5-triazine-2,4-diamine

6-(4-(2,2-Di(4-Fluorophenyl)ethylamino)-1-piperidinyl)-N,N-di-2-propenyl-1,3,5-triazine-2,4-diamine

C28H33F2N7 (505.2765)


D000970 - Antineoplastic Agents

   

[6-azaniumyl-1-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-4-hydroxy-6-(hydroxymethyl)-2-[(7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-3-ium-2-yl)amino]oxan-3-yl]amino]-1-oxohexan-3-yl]azanium

[6-azaniumyl-1-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-4-hydroxy-6-(hydroxymethyl)-2-[(7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-3-ium-2-yl)amino]oxan-3-yl]amino]-1-oxohexan-3-yl]azanium

C19H37N8O8+3 (505.2734)


   

streptothricin F(3+)

streptothricin F(3+)

C19H37N8O8+3 (505.2734)


   

Lnape 16:2/N-3:0

Lnape 16:2/N-3:0

C24H44NO8P (505.2804)


   

Lnape 3:0/N-16:2

Lnape 3:0/N-16:2

C24H44NO8P (505.2804)


   

Lnape 2:0/N-17:2

Lnape 2:0/N-17:2

C24H44NO8P (505.2804)


   

Lnape 17:2/N-2:0

Lnape 17:2/N-2:0

C24H44NO8P (505.2804)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C24H44NO8P (505.2804)


   

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C24H44NO8P (505.2804)


   

streptothricin F(3+)

streptothricin F(3+)

C19H37N8O8 (505.2734)


A primary aliphatic ammonium ion which is obtained from streptothricin F by protonation of the guanidino and amino groups.

   

phosphatidylcholine 16:2

phosphatidylcholine 16:2

C24H44NO8P (505.2804)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two phosphatidyl acyl groups contain a total of 16 carbons and 2 double bonds.

   

PE(19:2)

PE(8:0_11:2)

C24H44NO8P (505.2804)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PC(16:2)

PC(4:0_12:2)

C24H44NO8P (505.2804)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   

(2r,3r)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3,5-dihydroxy-8-[2-(4-hydroxyphenyl)ethyl]-2-methyl-3h,4h,9h-pyrano[2,3-e]isoindol-7-one

(2r,3r)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-3,5-dihydroxy-8-[2-(4-hydroxyphenyl)ethyl]-2-methyl-3h,4h,9h-pyrano[2,3-e]isoindol-7-one

C31H39NO5 (505.2828)


   

(4s,7r,8s,9s,15z,18s)-4,8-dihydroxy-5,7,9,11-tetramethyl-18-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

(4s,7r,8s,9s,15z,18s)-4,8-dihydroxy-5,7,9,11-tetramethyl-18-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

C28H43NO5S (505.2862)


   

(4s,5r,7r,8s,9s,11r,15z,18s)-4,8-dihydroxy-5,7,9,11-tetramethyl-18-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

(4s,5r,7r,8s,9s,11r,15z,18s)-4,8-dihydroxy-5,7,9,11-tetramethyl-18-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

C28H43NO5S (505.2862)


   

3,21,23-trihydroxy-6,8,10,12-tetramethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-5,16,18,22,28-pentaen-24-one

3,21,23-trihydroxy-6,8,10,12-tetramethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-5,16,18,22,28-pentaen-24-one

C31H39NO5 (505.2828)


   

4,8-dihydroxy-5,7,9,11-tetramethyl-18-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

4,8-dihydroxy-5,7,9,11-tetramethyl-18-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

C28H43NO5S (505.2862)


   

(1r,3r,4s,7s,8s,10r,12s,13r,21s,25s,26s)-3,21,23-trihydroxy-6,8,10,12-tetramethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-5,16,18,22,28-pentaen-24-one

(1r,3r,4s,7s,8s,10r,12s,13r,21s,25s,26s)-3,21,23-trihydroxy-6,8,10,12-tetramethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-5,16,18,22,28-pentaen-24-one

C31H39NO5 (505.2828)


   

(4s,7r,8s,9s,15z,18s)-4,8-dihydroxy-5,5,7,9-tetramethyl-18-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

(4s,7r,8s,9s,15z,18s)-4,8-dihydroxy-5,5,7,9-tetramethyl-18-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

C28H43NO5S (505.2862)


   

4,8-dihydroxy-5,5,7,9-tetramethyl-18-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

4,8-dihydroxy-5,5,7,9-tetramethyl-18-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclooctadec-15-ene-2,6-dione

C28H43NO5S (505.2862)


   

(1r,3r,4s,7s,8s,10r,12s,13r,14s,21r,25s,26s)-3,21,23-trihydroxy-6,8,10,12-tetramethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-5,16,18,22,28-pentaen-24-one

(1r,3r,4s,7s,8s,10r,12s,13r,14s,21r,25s,26s)-3,21,23-trihydroxy-6,8,10,12-tetramethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-5,16,18,22,28-pentaen-24-one

C31H39NO5 (505.2828)


   

(1r,3s,4s,7s,8s,10r,12s,13r,14s,21r,25s,26s)-3,21,23-trihydroxy-6,8,10,12-tetramethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-5,16,18,22,28-pentaen-24-one

(1r,3s,4s,7s,8s,10r,12s,13r,14s,21r,25s,26s)-3,21,23-trihydroxy-6,8,10,12-tetramethyl-15-oxa-22-azaheptacyclo[12.9.3.2¹⁶,¹⁹.1¹,²¹.0⁴,²⁵.0⁷,²⁶.0⁸,¹³]nonacosa-5,16,18,22,28-pentaen-24-one

C31H39NO5 (505.2828)